LRCH4
Leucine-rich repeat and calponin homology domain-containing protein 4
Also known as: LRCH4_HUMAN, LRN, LRRN1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75427
- Gene
- LRCH4
- Ensembl
- ENSG00000077454
- Chromosome
- 7
- Canonical length
- 683 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Focal adhesion sites,Cytosol
OverviewNCBI Gene
This gene encodes a protein that contains leucine-rich repeats (LRR) at its amino terminus and that is known to be involved in ligand binding. The carboxyl terminus may act as a membrane anchor. Identified structural elements suggest that the encoded protein resembles a receptor. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
683 residues, UniProt reviewed canonical sequence.
>O75427|LRCH4
1 MAAAVAAPLA AGGEEAAATT SVPGSPGLPG RRSAERALEE AVATGTLNLS NRRLKHFPRG
61 AARSYDLSDI TQADLSRNRF PEVPEAACQL VSLEGLSLYH NCLRCLNPAL GNLTALTYLN
121 LSRNQLSLLP PYICQLPLRV LIVSNNKLGA LPPDIGTLGS LRQLDVSSNE LQSLPSELCG
181 LSSLRDLNVR RNQLSTLPEE LGDLPLVRLD FSCNRVSRIP VSFCRLRHLQ VILLDSNPLQ
241 SPPAQVCLKG KLHIFKYLST EAGQRGSALG DLAPSRPPSF SPCPAEDLFP GHRYDGGLDS
301 GFHSVDSGSK RWSGNESTDE FSELSFRISE LAREPRGPRE RKEDGSADGD PVQIDFIDSH
361 VPGEDEERGT VEEQRPPELS PGAGDRERAP SSRREEPAGE ERRRPDTLQL WQERERRQQQ
421 QSGAWGAPRK DSLLKPGLRA VVGGAAAVST QAMHNGSPKS SASQAGAAAG QGAPAPAPAS
481 QEPLPIAGPA TAPAPRPLGS IQRPNSFLFR SSSQSGSGPS SPDSVLRPRR YPQVPDEKDL
541 MTQLRQVLES RLQRPLPEDL AEALASGVIL CQLANQLRPR SVPFIHVPSP AVPKLSALKA
601 RKNVESFLEA CRKMGVPEAD LCSPSDLLQG TARGLRTALE AVKRVGGKAL PPLWPPSGLG
661 GFVVFYVVLM LLLYVTYTRL LGSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LRCH4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 112 nTPM
Expression across tissuesHPA
Tissue
- spleen: 112 nTPM
- testis: 79 nTPM
- small intestine: 60 nTPM
- bone marrow: 57 nTPM
- ovary: 53 nTPM
- lung: 48 nTPM
Single-cell type
- astrocytes: 24 nCPM
- tuft cells: 23 nCPM
- podocytes: 20 nCPM
- renal collecting duct intercalated cells: 18 nCPM
- choroid plexus epithelial cells: 14 nCPM
- microglia: 14 nCPM
Immune cell
- neutrophil: 16 nTPM
- eosinophil: 10 nTPM
- basophil: 10 nTPM
- classical monocyte: 5.6 nTPM
- naive CD4 T-cell: 5.2 nTPM
- naive B-cell: 5.1 nTPM
Brain region
- white matter: 39 nTPM
- medulla oblongata: 36 nTPM
- cerebral cortex: 33 nTPM
- thalamus: 33 nTPM
- pons: 32 nTPM
- basal ganglia: 29 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.68
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.12
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- membrane raft assembly
- nervous system development
- positive regulation of toll-like receptor signaling pathway
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LRCH4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LRCH4 as an antibody target. Whether an autoantibody or antibody against LRCH4 could matter depends on whether native LRCH4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LRCH4 is annotated at the cell surface, where native LRCH4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label LRCH4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...